Urgent Action on Tackling Antibiotic Resistance
Abstract
No Abstract
1. Lee J H, Park KS, Karim AM, Lee C-R, Lee SH (2016). How to minimize an-tibiotic resistance. Lancet Infect Dis, 16: 17-18.
2. Kahn LH (2017). Perspective: The one-health way. Nature, 543: S47.
3. Tran-Dien A, Le Hello S, Bouchier C, Weill FX (2017). Early transmissible ampicillin resistance in zoonotic Sal-monella enterica serotype Typhimurium in the late 1950s: a retrospective, whole-genome sequencing study. Lan-cet Infect Dis, 18: 207-214.
4. Editorial (2018). Progress on antibiotic re-sistance. Nature, 56: 307.
5. Lee JH, Jeong SH, Cha S, Lee SH (2007). A lack of drugs for antibiotic-resistant Gram-negative bacteria. Nat Rev Drug Dis-cov, 6: 938-939.
6. Theuretzbacher U, Gottwalt S, Beyer P, et al (2019). Analysis of the clinical antibacterial and antituberculosis pipeline. Lancet Infect Dis, 19: e40-e50.
2. Kahn LH (2017). Perspective: The one-health way. Nature, 543: S47.
3. Tran-Dien A, Le Hello S, Bouchier C, Weill FX (2017). Early transmissible ampicillin resistance in zoonotic Sal-monella enterica serotype Typhimurium in the late 1950s: a retrospective, whole-genome sequencing study. Lan-cet Infect Dis, 18: 207-214.
4. Editorial (2018). Progress on antibiotic re-sistance. Nature, 56: 307.
5. Lee JH, Jeong SH, Cha S, Lee SH (2007). A lack of drugs for antibiotic-resistant Gram-negative bacteria. Nat Rev Drug Dis-cov, 6: 938-939.
6. Theuretzbacher U, Gottwalt S, Beyer P, et al (2019). Analysis of the clinical antibacterial and antituberculosis pipeline. Lancet Infect Dis, 19: e40-e50.
Files | ||
Issue | Vol 50 No 9 (2021) | |
Section | Letter to the Editor | |
DOI | https://doi.org/10.18502/ijph.v50i9.7064 |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Lee JH, Kim TY, Malik SK, Jeon JH, Kim YB, Lee SH. Urgent Action on Tackling Antibiotic Resistance. Iran J Public Health. 2021;50(9):1902-1903.